世界のカボザンチニブ市場予測（～2028年）：カプセル、錠剤

• 英文タイトル：Global Cabozantinib Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8757 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

カボザンチニブ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のカボザンチニブの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 カボザンチニブ市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・カプセル、錠剤 用途別セグメントは次のように区分されます。 ・甲状腺髄様がん治療、腎細胞がん二次治療 世界のカボザンチニブ市場の主要な市場プレーヤーは以下のとおりです。 ・Exelixis、Tecoland Corporation、Fermion Oy、Sun Pharmaceutical Industries Limit、MSN Laboratories Pvt Ltd、Shanghai Hope Chem、Hetero Drugs Limited、Huateng Pharmaceutical Co.、Bio Nova Pharmaceuticals Private Limited、AlchemyPharm 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、カボザンチニブ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なカボザンチニブメーカーの企業概要、2019年～2022年までのカボザンチニブの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なカボザンチニブメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別カボザンチニブの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのカボザンチニブの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのカボザンチニブ市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびカボザンチニブの産業チェーンを掲載しています。 ・第13、14、15章では、カボザンチニブの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Exelixis、Tecoland Corporation、Fermion Oy、Sun Pharmaceutical Industries Limit、MSN Laboratories Pvt Ltd、Shanghai Hope Chem、Hetero Drugs Limited、Huateng Pharmaceutical Co.、Bio Nova Pharmaceuticals Private Limited、AlchemyPharm ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：カプセル、錠剤 ・用途別分析2017年-2028年：甲状腺髄様がん治療、腎細胞がん二次治療 ・カボザンチニブの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・カボザンチニブのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・カボザンチニブのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・カボザンチニブの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・カボザンチニブの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Cabozantinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cabozantinib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medullary Thyroid Cancer Treatment accounting for % of the Cabozantinib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Capsule segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cabozantinib include Exelixis, Tecoland Corporation, Fermion Oy, Sun Pharmaceutical Industries Limit, and MSN Laboratories Pvt Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cabozantinib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsule
Tablet
Market segment by Application can be divided into
Medullary Thyroid Cancer Treatment
Second Line Treatment for Renal Cell Carcinoma
The key market players for global Cabozantinib market are listed below:
Exelixis
Tecoland Corporation
Fermion Oy
Sun Pharmaceutical Industries Limit
MSN Laboratories Pvt Ltd
Shanghai Hope Chem
Hetero Drugs Limited
Huateng Pharmaceutical Co.
Bio Nova Pharmaceuticals Private Limited
AlchemyPharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cabozantinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cabozantinib, with price, sales, revenue and global market share of Cabozantinib from 2019 to 2022.
Chapter 3, the Cabozantinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cabozantinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cabozantinib market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cabozantinib.
Chapter 13, 14, and 15, to describe Cabozantinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Cabozantinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cabozantinib Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Cabozantinib Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Medullary Thyroid Cancer Treatment
1.3.3 Second Line Treatment for Renal Cell Carcinoma
1.4 Global Cabozantinib Market Size & Forecast
1.4.1 Global Cabozantinib Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cabozantinib Sales in Volume (2017-2028)
1.4.3 Global Cabozantinib Price (2017-2028)
1.5 Global Cabozantinib Production Capacity Analysis
1.5.1 Global Cabozantinib Total Production Capacity (2017-2028)
1.5.2 Global Cabozantinib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cabozantinib Market Drivers
1.6.2 Cabozantinib Market Restraints
1.6.3 Cabozantinib Trends Analysis
2 Manufacturers Profiles
2.1 Exelixis
2.1.1 Exelixis Details
2.1.2 Exelixis Major Business
2.1.3 Exelixis Cabozantinib Product and Services
2.1.4 Exelixis Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Tecoland Corporation
2.2.1 Tecoland Corporation Details
2.2.2 Tecoland Corporation Major Business
2.2.3 Tecoland Corporation Cabozantinib Product and Services
2.2.4 Tecoland Corporation Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Fermion Oy
2.3.1 Fermion Oy Details
2.3.2 Fermion Oy Major Business
2.3.3 Fermion Oy Cabozantinib Product and Services
2.3.4 Fermion Oy Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharmaceutical Industries Limit
2.4.1 Sun Pharmaceutical Industries Limit Details
2.4.2 Sun Pharmaceutical Industries Limit Major Business
2.4.3 Sun Pharmaceutical Industries Limit Cabozantinib Product and Services
2.4.4 Sun Pharmaceutical Industries Limit Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 MSN Laboratories Pvt Ltd
2.5.1 MSN Laboratories Pvt Ltd Details
2.5.2 MSN Laboratories Pvt Ltd Major Business
2.5.3 MSN Laboratories Pvt Ltd Cabozantinib Product and Services
2.5.4 MSN Laboratories Pvt Ltd Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Shanghai Hope Chem
2.6.1 Shanghai Hope Chem Details
2.6.2 Shanghai Hope Chem Major Business
2.6.3 Shanghai Hope Chem Cabozantinib Product and Services
2.6.4 Shanghai Hope Chem Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hetero Drugs Limited
2.7.1 Hetero Drugs Limited Details
2.7.2 Hetero Drugs Limited Major Business
2.7.3 Hetero Drugs Limited Cabozantinib Product and Services
2.7.4 Hetero Drugs Limited Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Huateng Pharmaceutical Co.
2.8.1 Huateng Pharmaceutical Co. Details
2.8.2 Huateng Pharmaceutical Co. Major Business
2.8.3 Huateng Pharmaceutical Co. Cabozantinib Product and Services
2.8.4 Huateng Pharmaceutical Co. Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bio Nova Pharmaceuticals Private Limited
2.9.1 Bio Nova Pharmaceuticals Private Limited Details
2.9.2 Bio Nova Pharmaceuticals Private Limited Major Business
2.9.3 Bio Nova Pharmaceuticals Private Limited Cabozantinib Product and Services
2.9.4 Bio Nova Pharmaceuticals Private Limited Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 AlchemyPharm
2.10.1 AlchemyPharm Details
2.10.2 AlchemyPharm Major Business
2.10.3 AlchemyPharm Cabozantinib Product and Services
2.10.4 AlchemyPharm Cabozantinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cabozantinib Breakdown Data by Manufacturer
3.1 Global Cabozantinib Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cabozantinib Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cabozantinib
3.4 Market Concentration Rate
3.4.1 Top 3 Cabozantinib Manufacturer Market Share in 2021
3.4.2 Top 6 Cabozantinib Manufacturer Market Share in 2021
3.5 Global Cabozantinib Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cabozantinib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cabozantinib Market Size by Region
4.1.1 Global Cabozantinib Sales in Volume by Region (2017-2028)
4.1.2 Global Cabozantinib Revenue by Region (2017-2028)
4.2 North America Cabozantinib Revenue (2017-2028)
4.3 Europe Cabozantinib Revenue (2017-2028)
4.4 Asia-Pacific Cabozantinib Revenue (2017-2028)
4.5 South America Cabozantinib Revenue (2017-2028)
4.6 Middle East and Africa Cabozantinib Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cabozantinib Sales in Volume by Type (2017-2028)
5.2 Global Cabozantinib Revenue by Type (2017-2028)
5.3 Global Cabozantinib Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cabozantinib Sales in Volume by Application (2017-2028)
6.2 Global Cabozantinib Revenue by Application (2017-2028)
6.3 Global Cabozantinib Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cabozantinib Sales by Type (2017-2028)
7.2 North America Cabozantinib Sales by Application (2017-2028)
7.3 North America Cabozantinib Market Size by Country
7.3.1 North America Cabozantinib Sales in Volume by Country (2017-2028)
7.3.2 North America Cabozantinib Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cabozantinib Sales by Type (2017-2028)
8.2 Europe Cabozantinib Sales by Application (2017-2028)
8.3 Europe Cabozantinib Market Size by Country
8.3.1 Europe Cabozantinib Sales in Volume by Country (2017-2028)
8.3.2 Europe Cabozantinib Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cabozantinib Sales by Type (2017-2028)
9.2 Asia-Pacific Cabozantinib Sales by Application (2017-2028)
9.3 Asia-Pacific Cabozantinib Market Size by Region
9.3.1 Asia-Pacific Cabozantinib Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cabozantinib Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cabozantinib Sales by Type (2017-2028)
10.2 South America Cabozantinib Sales by Application (2017-2028)
10.3 South America Cabozantinib Market Size by Country
10.3.1 South America Cabozantinib Sales in Volume by Country (2017-2028)
10.3.2 South America Cabozantinib Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cabozantinib Sales by Type (2017-2028)
11.2 Middle East & Africa Cabozantinib Sales by Application (2017-2028)
11.3 Middle East & Africa Cabozantinib Market Size by Country
11.3.1 Middle East & Africa Cabozantinib Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cabozantinib Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cabozantinib and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cabozantinib
12.3 Cabozantinib Production Process
12.4 Cabozantinib Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cabozantinib Typical Distributors
13.3 Cabozantinib Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---